圧迫療法市場規模、成長と動向分析レポート 2026-2033年

世界の圧迫療法市場規模は、2025年には44億3,000万米ドルと推定され、2033年には58億8,000万米ドルに達すると予測されています。2026年から2033年にかけて年平均成長率（CAGR）3.54%で成長し、深部静脈血栓症（DVT）、静脈瘤、リンパ浮腫、慢性静脈不全などの静脈およびリンパ系疾患の罹患率の上昇がその成長を牽引しています。血行を改善し、腫れを軽減するために制御された圧力を加える圧迫療法は、これらの疾患の予防と治療の両方にとって不可欠な解決策となっています。

主要市場動向とインサイト

• 北米は、2025年に42.10%という最大の収益シェアを獲得し、圧迫療法市場を牽引しました。
• 北米市場において、2025年の収益シェアは米国が最大となりました。
• 技術タイプ別では、静的圧迫療法セグメントが2025年に最大の収益シェアを獲得し、市場をリードしました。
• 流通チャネル別では、医療機関向け販売セグメントが2025年に最大の収益シェアを獲得し、市場をリードしました。
• エンドユーザー別では、病院向けセグメントが2025年に最大の収益シェアを獲得し、市場をリードしました。

肥満、糖尿病、心血管疾患といった慢性疾患の負担増大に加え、循環器疾患にかかりやすい高齢化が急速に進む世界人口も、この成長をさらに後押ししています。さらに、外科手術やスポーツ関連の怪我の増加も、術後ケアやリハビリテーションにおける圧迫療法の需要を高めています。

整形外科手術件数の増加に伴い、術後ケアおよびリハビリテーションの一環として、圧迫療法へのニーズが高まっています。関節置換術（膝関節置換術や股関節置換術など）、骨折修復術、靭帯再建術、関節鏡手術といった整形外科手術は、高齢化、スポーツ関連の怪我、手術技術の進歩といった要因により、ますます一般的になっています。例えば、米国リウマチ学会のデータによると、米国では高齢化に伴い、年間約79万件の膝関節置換術と約54万4千件の股関節置換術が実施されており、膝関節置換術と股関節置換術の件数は増加傾向にあります。オーストラリア整形外科学会全国関節置換術登録（AOANJRR）が2024年に発表したデータによると、オーストラリアでは210万件以上の整形外科手術が実施されました。

整形外科手術後、患者は一般的に、手術を受けた四肢の腫れ、炎症、可動域の制限を経験します。圧迫療法は、血行促進、腫れ軽減、手術部位のサポートなどにより、これらの術後症状の管理と回復において重要な役割を果たします。

本レポートは、地域別および国別の収益成長を予測し、2021年から2033年までの各サブセグメントにおける最新の業界動向を分析しています。本調査において、グランドビューリサーチは、圧迫療法市場レポートを技術、最終用途、流通チャネル、および地域に基づいてセグメント化しました。

Compression Therapy Market Summary

The global compression therapy market size was estimated at USD 4.43 billion in 2025 and is projected to reach USD 5.88 billion by 2033, growing at a CAGR of 3.54% from 2026 to 2033, driven by the rising prevalence of venous and lymphatic disorders such as Deep Vein Thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. Compression therapy, which applies controlled pressure to improve blood circulation and reduce swelling, has become an essential solution for both prevention and treatment of these conditions.

compression-therapy-market-snapshot

Key Market Trends & Insights

• North America dominated the compression therapy market with the largest revenue share of 42.10% in 2025.
• The market in the U.S. accounted for the largest market revenue share in North America in 2025.
• By technology type, the static compression therapy segment led the market with the largest revenue share in 2025.
• By distribution channel, the institutional sales segment led the market with the largest revenue share in 2025.
• By end use, the hospitals segment led the market with the largest revenue share in 2025.

Market Size & Forecast

• 2025 Market Size: USD 4.43 Billion
• 2033 Projected Market Size: USD 5.88 Billion
• CAGR (2026-2033): 3.54%
• North America: Largest market in 2025
• Asia Pacific: Fastest growing market

Growth is further fueled by the increasing burden of chronic diseases such as obesity, diabetes, and cardiovascular conditions, along with a rapidly aging global population that is more susceptible to circulatory disorders. In addition, the rising number of surgical procedures and sports-related injuries is boosting demand for compression therapy in post-operative care and rehabilitation.

The rising prevalence of Deep Vein Thrombosis (DVT) is significantly growing the compression therapy market, as the condition requires effective prevention and management strategies to reduce complications. DVT, which involves the formation of blood clots in deep veins primarily in the legs, is becoming more common due to factors such as sedentary lifestyles, increasing obesity rates, an aging population, and a higher number of surgical procedures. Compression therapy, including stockings and pneumatic devices, is widely recommended to improve blood circulation, prevent clot formation, and reduce the risk of post-thrombotic complications.

• According to the Centers for Disease Control and Prevention (CDC) data from 2025, up to 900,000 people in the U.S. are affected by venous thromboembolism (VTE) each year, highlighting the significant burden of this condition on the healthcare system.

Conditions such as chronic venous insufficiency and venous ulcers impact many people worldwide, with factors such as aging populations, inactive lifestyles, and obesity playing a major role. Compression therapy for venous ulcers is highly effective; therefore, the rising prevalence of venous ulcers will drive market growth in the near future. Moreover, compression therapy for varicose veins is a highly effective treatment compared to other options. For instance, data from the Society for Vascular Surgery indicate that as many as 40 million Americans have varicose veins. Moreover, according to an article published by NCBI, around 150,000 new cases of chronic venous insufficiency are diagnosed each year, with approximately USD 500 million spent on the care of these patients.

Compression therapy works by applying controlled pressure to the affected limbs, helping ease symptoms, enhance blood flow, reduce swelling, and aid healing, while preventing complications. Thus, the growing awareness of compression therapy’s effectiveness in managing chronic venous conditions is expected to drive market growth.

The growing number of orthopedic procedures is driving an increased need for compression therapy as part of postoperative care and rehabilitation protocols. Orthopedic surgeries, including joint replacements (such as knee or hip replacements), fracture repairs, ligament reconstructions, and arthroscopic surgeries, are becoming more common due to factors such as an aging population, sports-related injuries, and advancements in surgical techniques. For instance, according to data from the American College of Rheumatology, the number of knee and hip replacements performed annually in the U.S. is on the rise due to the aging population, with approximately 790,000 knee replacements and 544,000 hip replacements performed each year. According to data published by the Australian Orthopedic Association National Joint Replacement Registry (AOANJRR) in 2024, more than 2.1 million orthopedic procedures were performed in Australia.

After an orthopedic procedure, patients commonly experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy plays a vital role in managing these postoperative symptoms and in providing recovery by improving blood circulation, reducing swelling, and supporting the surgical site.

The increasing cases of obesity have led to an increase in the adoption of compression therapy as a crucial device in managing health-related concerns. Obesity, characterized by excessive body fat accumulation, not only increases the risk of chronic disorders such as CVD, diabetes, & hypertension but also contributes to venous insufficiency and associated disorders. For instance, an article published in the International Journal of Medical Science and Clinical Invention suggests that obesity increases the risk of venous insufficiency and associated complications by more than sixfold. As per the World Obesity Federation, in 2024, more than one billion people worldwide were living with obesity, which is about one in eight people. This includes nearly 880 million adults, and 159 million children and adolescents aged 5-19. The World Obesity Federation’s 2025 Atlas, published on World Obesity Day (4 March), projects that the total number of adults living with obesity will increase by more than 115% between 2010 and 2030, from 524 million to 1.13 billion.

The table below indicates the Prevalence of Obesity in the U.S. based on Self-Reported Weight and Height by State and Territory, Behavioral Risk Factor Surveillance System BRFSS, 2024

Obesity can worsen venous insufficiency by increasing venous pressure, especially in the lower limbs. The additional weight places strain on the venous system, hindering blood flow back to the heart and leading to venous congestion, swelling, and discomfort. Over time, this chronic venous insufficiency can progress to more serious conditions such as varicose veins, venous ulcers, and DVT. Thus, this factor is expected to surge demand for compression therapy, driving market growth.

Market Dynamics

The increasing prevalence of chronic venous disorders, including chronic venous insufficiency (CVI), varicose veins, deep vein thrombosis (DVT), and venous leg ulcers, is a key driver of the compression therapy market. Factors such as sedentary lifestyles, obesity, aging populations, and prolonged periods of standing or sitting at work are significantly contributing to the growing global burden of these conditions. According to data published by the Society for Vascular Surgery in July 2025, chronic venous insufficiency affects up to 40% of Americans. Similarly, data from WebMD LLC published in July 2025 indicate that in the U.S., more than 11 million men and 22 million women aged 40–80 years suffer from varicose veins, while over 2 million individuals are affected by advanced CVI. Each year, more than 20,000 people are diagnosed with ulcers resulting from CVI.

Restraint – Alternative Treatment Method

The growing availability of alternative treatment methods is restraining the adoption of traditional compression therapy products. Minimally invasive procedures such as endovenous laser therapy (EVLT), radiofrequency ablation (RFA), foam sclerotherapy, and vein stenting are preferred for the treatment of chronic venous disease due to faster recovery, long-term symptom relief, and improved patient convenience. In June 2025, the Society for Cardiovascular Angiography & Interventions published updated chronic venous disease guidelines highlighting ablation therapy, sclerotherapy, and venous interventions alongside conservative compression approaches, reflecting the growing clinical acceptance of alternative treatments. Furthermore, in December 2025, a study published on ResearchGate highlighted the growing adoption of minimally invasive procedures and novel pharmacological therapies for chronic venous insufficiency, which are improving patient outcomes and reducing dependence on conventional compression therapy as a standalone treatment approach.

Market Concentration & Characteristics

The market’s growth stage is moderate, and the pace is accelerating. Key characteristics include strong demand driven by the rising prevalence of chronic venous disorders and an aging population, along with increasing preference for non-invasive treatment options. In addition, the market is innovation-oriented, with continuous advancements in materials, product design, and digital integration aimed at improving patient comfort, compliance, and therapeutic outcomes. Strategic expansion into home care settings, coupled with growing awareness and reimbursement support in developed regions, further shapes the market’s competitive and operational dynamics.

The compression therapy market is characterized by strong, evolving innovation driven by the need to enhance clinical outcomes and improve patient experience. Advancements center on the development of smart compression systems that deliver adjustable, personalized pressure and integrate digital features, such as Bluetooth connectivity and mobile applications, for real-time monitoring and therapy tracking. Innovations in materials and product design, including lightweight, breathable, and ergonomically designed garments, are improving comfort and patient adherence, especially for long-term use. For instance, Hyperice launched Hyperice X 2 Knee and X 2 Shoulder devices, which feature integrated compression alongside heat and cold therapy. These devices provide multi-modal treatment in a single wearable system, improving circulation and accelerating recovery for musculoskeletal conditions. In addition, the introduction of portable and user-friendly pneumatic compression devices is supporting the shift toward home-based care, making treatment more accessible and convenient. While the fundamental concept of compression therapy remains consistent, continuous technological enhancements are significantly transforming product capabilities and overall market dynamics.

compression-therapy-industry-dynamics

Compression therapy products are medical devices subject to strict regulatory standards. Regulatory bodies, such as the U.S. FDA in the U.S. or CE (Conformité Européene) marking in Europe, set guidelines and standards to ensure the safety, effectiveness, and quality of these devices. Innovation in compression therapy product design, materials, and features often requires regulatory approvals. Manufacturers must navigate the regulatory landscape to ensure new and improved products meet the required standards. For instance, in 2026, AIROS Medical, a medical technology manufacturer specializing in compression therapy systems for peripheral vascular disorders, announced the launch of its U.S. Food and Drug Administration (FDA)- cleared 510(k) ARTAIRA® arterial compression device. Regulatory bodies set quality and safety standards for medical equipment, including compression therapy. Compliance with these standards is essential for manufacturers to ensure patient safety during transportation. In addition, regulations may require manufacturers to adopt eco-friendly practices in the production and disposal of compression therapy products.

Mergers and acquisitions are driving growth in the compression therapy market by enabling companies to expand their technological capabilities, product offerings, and geographic presence. Through strategic acquisitions, companies gain access to advanced compression technologies and innovative product lines, which enhance their ability to meet evolving patient needs and improve treatment outcomes. These activities also strengthen distribution networks and allow faster entry into emerging markets, increasing overall market penetration. In addition, consolidation through mergers creates stronger entities with greater financial and research resources, accelerating product development and commercialization. As a result, rising M&A activity is contributing to increased competition, innovation, and overall market expansion.

In February 2026, Tactile Medical announced the acquisition of LymphaTech to expand the breadth and depth of its lymphedema solutions portfolio. The acquisition, valued at an upfront payment of USD 6.8 million with additional milestone-based considerations, strengthens Tactile Medical’s position in lymphatic disease management.

Regional Expansion

Regional expansion in the global market involves introducing new products or enhancing existing ones to meet evolving patient needs, technological advancements, and market demands. Companies can introduce new product lines to target specific market segments. This might include developing compression garments for different anatomical areas, such as arms, legs, torso, or specific conditions, such as lymphedema or venous insufficiency.

The market exhibits elements of both fragmentation and consolidation, with the degree varying by product type, geographic region, and market segment. In certain segments of the market, particularly in regions with a wide range of manufacturers and suppliers, the market can be fragmented. This fragmentation may be due to the presence of numerous small- and medium-sized companies offering a range of compression therapy products, including compression garments, bandages, stockings, and devices. These companies often compete based on factors such as price, product differentiation, and distribution channels. Conversely, the market is characterized by consolidation, particularly in segments dominated by a few large companies with significant market share. These companies may have established brand recognition, extensive distribution networks, and diverse product portfolios encompassing a range of compression therapy solutions.

The market is influenced by various factors, including advancements in healthcare infrastructure, the rising prevalence of chronic diseases, and technological innovations in compression therapy, such as improved designs that enhance patient comfort & compliance. Regional expansion scenarios in the market are driven by factors such as an aging population, the rising prevalence of chronic diseases, increased awareness of venous disorders, and the overall development of healthcare infrastructure.

Technology Insights

Based on technology, the static compression therapy segment led the market, accounting for the largest revenue share in 2025. Static compression therapy involves applying consistent pressure to affected areas to increase blood flow and reduce swelling. This method utilizes compression garments such as stockings, bandages, or wraps, known for their ease and effectiveness in treating conditions like varicose veins, Deep Vein Thrombosis (DVT), and lymphedema. The therapy is favored for its ease of use and convenience, making it a preferred choice for both patients and physicians. It offers effective pressure & pain relief, rapid functional recovery, and reduced swelling, which are crucial for treating various sports injuries & conditions. Static compression devices are versatile, suitable for various medical conditions, and offer various levels of compression. They are relatively more affordable than dynamic compression devices, making them a cost-effective option for patients and healthcare providers, especially in regions with limited healthcare budgets.

The dynamic compression therapy segment is expected to register the fastest growth during the forecast period. This therapy is gaining traction in the market, driven by several key factors and trends. This therapy involves applying pressure to the affected area, gradually adjusting it to promote blood flow and reduce swelling. The therapy products include dynamic compression pumps. Dynamic compression therapy offers a flexible approach, allowing pressure levels to be adjusted based on patient needs, unlike static compression therapy, which applies constant pressure. This flexibility makes it effective for treating various conditions, including postsurgical wounds and injury pains.

End Use Insights

Based on end use, the hospitals segment accounted for the largest revenue share in 2025. Hospitals are preferred over other healthcare facilities due to their capability to provide comprehensive care to patients with complex medical needs. Hospitals have the necessary infrastructure, medical expertise, and resources to effectively manage & monitor patients’ conditions, ensuring optimal treatment outcomes. In addition, they offer immediate access to advanced medical care in the event of complications or emergencies. Compression therapy products are widely used in hospitals for the treatment of various medical conditions, including venous disorders, lymphedema, and postsurgical recovery. The use of these products in hospitals has increased due to their proven efficacy in managing conditions, reducing complications, and improving patient outcomes.

The home healthcare segment is expected to register the fastest CAGR in the forecast period. Compression therapy at home healthcare is utilized for the management of conditions such as varicose veins, DVT, lymphedema, orthostatic hypotension, sports injuries, and leg ulcers. Home-based healthcare and patient self-management strategies have increased demand for user-friendly, wearable compression therapy devices. These devices are designed to be easy to use at home, allowing patients to manage their conditions without frequent visits to healthcare facilities. Integrating compression therapy consultations, fitting services, and patient education into telemedicine platforms further enhances access to care and supports remote patient monitoring initiatives.

Distribution Channel Insights

Based on the distribution channel, the institutional sales segment accounted for the largest revenue share in 2025. Institutional sales in the global market involve distributing products through channels such as hospitals, clinics, & nursing homes and offer several advantages over retail sales. These advantages include selling products in larger quantities, reduced marketing costs, and the potential to establish long-term business relationships with key institutional customers. The dominance of institutional sales in the market is driven by increasing demand for these products in healthcare settings. As the global population ages, there is a growing need for compression therapy solutions to treat conditions such as chronic venous insufficiency, lymphedema, and DVT. Institutional sales offer an effective and dependable way to deliver these products to healthcare providers who require them.

compression-therapy-market-share

The retail sales segment is expected to register the fastest CAGR during the forecast period. Retail sales in the market encompass the distribution of products through channels such as pharmacies, medical supply stores, and online retailers. Retail sales offer greater accessibility to compression therapy products, providing a wide range of options and allowing consumers to compare & select the best products for their needs. In addition, retail sales offer convenience, enabling consumers to purchase products directly without a prescription or a visit to a healthcare provider. Hence, rising benefits associated with retail sales are anticipated to boost the segment growth.

Regional Insights

North America dominated the compression therapy market with a 42.10% revenue share in 2025, driven by technological advancements, the rising prevalence of chronic diseases, and government initiatives. The market’s expansion is further bolstered by advancements in compression therapy technology, such as the development of innovative materials and improved designs that enhance patient comfort & compliance. The increasing prevalence of chronic diseases such as diabetes and obesity, which often lead to circulatory issues, significantly contributes to market growth. For instance, in 2025, chronic venous insufficiency, known to most by its most typical symptom, varicose veins, is quite common. About one in four U.S. adults has chronic venous insufficiency. If you count spider veins, it’s more like eight in 10 of us.

U.S. Compression Therapy Market Trends

The U.S. market for compression therapy is growing, driven by the increasing prevalence of venous and lymphatic disorders such as Varicose Veins, deep vein thrombosis (DVT), and chronic venous insufficiency. The rising prevalence of varicose veins is a major driver, as they affect a significant portion of the adult population due to factors such as sedentary lifestyles, prolonged standing or sitting, obesity, and aging. For instance, more than 40 million people in the U.S. suffer from varicose veins. Almost 50% of patients with varicose veins have a family history of varicose veins. If both parents have varicose veins, your chances of developing the disease are close to 90%. These conditions lead to symptoms like leg pain, swelling, and visible vein enlargement, prompting patients to seek effective and non-invasive treatment options such as compression therapy. Increasing awareness and early diagnosis of varicose veins are further accelerating the adoption of compression stockings and bandages for both prevention and long-term management. Rising healthcare awareness, increasing preference for preventive care, and the integration of compression therapy in post-surgical recovery and rehabilitation are strengthening market growth.

Europe Compression Therapy Market Trends

The compression therapy market in Europe is expected to grow at a significant CAGR over the forecast period. This growth can be attributed to the rising geriatric population and growing advancements in the market. Moreover, the region’s advanced healthcare infrastructure, coupled with a focus on minimally invasive medical interventions, fosters the adoption of compression therapy products.

The UK compression therapy market is expected to grow at a moderate CAGR over the forecast period.The aging population in the UK, prone to venous ulcers, foot ulcers, and edema, necessitates the use of compression therapy to prevent recurrence & manage symptoms. The high incidence of DVT, affecting 1 to 2 out of every 1,000 people annually, which increases with age, underscores the importance of compression therapy in DVT management. Compression therapy, including compression hosiery, bandaging, or other devices, plays a critical role in DVT management. According to data published by the National Library of Medicine in 2025, hospitalizations for VTE increased by 62.6% between 1998 and 2022, from 109.5 to 178.1 per 100,000 population. This was driven by a 202% increase in hospitalizations for PE (from 40.4 to 122.2 per 100,000 population).

The compression therapy market in France is expected to grow at the fastest CAGR over the forecast period, driven by the rising geriatric population and the increasing prevalence of CVDs in the region. The country’s aging population is contributing to a higher incidence of venous and lymphatic disorders such as varicose veins, lymphedema, and deep vein thrombosis, thereby increasing the demand for compression-based treatments. In 2024, a study published by the National Library of Medicine reported that the number of venous thromboembolism cases among adults in France reached 896,846 on 1 January 2023. VTE was the primary diagnosis during a hospital stay or in a medical unit for 62,055 patients hospitalized in 2022. The age-standardized rate of hospitalized patients was 23.0% higher among men than among women. In addition, rising cases of obesity and sedentary lifestyles are further driving the need for effective, non-invasive therapeutic solutions. France’s well-established healthcare system, which reimburses for compression garments and devices, enhances patient access to and adoption of these treatments.

Asia Pacific Compression Therapy Market Trends

The compression therapy market in the Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period. The Asia Pacific market has been experiencing significant growth, driven by several key factors, including the increasing prevalence of chronic diseases, including venous disorders, lymphedema, and DVT, among the region’s population. Moreover, the rising geriatric population, coupled with the growing awareness about the benefits of compression therapy in managing such conditions, has further fueled market expansion. Technological advancements, such as innovative compression garment designs & materials, have enhanced patient comfort and compliance, boosting market demand.

China compression therapy market is experiencing growth, supported by a rapidly aging population and a rising burden of chronic diseases. The country has a large elderly demographic, which significantly increases the prevalence of conditions such as chronic venous insufficiency, lymphedema, and varicose veins, all of which require compression-based treatment. In addition, supportive government healthcare initiatives and ongoing improvements in healthcare infrastructure are playing a crucial role in strengthening the market, positioning China as a key growth region for compression therapy. For instance, A major factor supporting market expansion is the Healthy China 2030 strategy, introduced by the Chinese government to strengthen the national healthcare system and improve disease prevention, diagnosis, and treatment services. The policy focuses on improving healthcare access, expanding medical coverage, strengthening disease prevention programs, and promoting advanced medical technologies to enhance healthcare outcomes.

The India compression therapy market is growing in the compression therapy sector, driven strongly by the rising prevalence of chronic diseases, particularly diabetes, which is significantly contributing to vascular complications. The increasing number of diabetic patients in the country is leading to a higher incidence of conditions such as poor blood circulation, diabetic foot ulcers, and chronic venous insufficiency, all of which require compression therapy as part of effective management and recovery. As per the International Diabetes Federation, India’s diabetes cases in adults are 89,826,900 in 2024, and the prevalence of diabetes is 10.5%. As diabetes continues to rise due to sedentary lifestyles, unhealthy dietary habits, and urbanization, the demand for compression garments, stockings, and bandages is also increasing steadily. In addition, the growing burden of Deep Vein Thrombosis (DVT) is further supporting market expansion, as prolonged sitting, long travel, obesity, and rising surgical procedures increase the risk of clot formation. Improved awareness and early diagnosis are encouraging the use of compression therapy for both prevention and post-treatment care.

Latin America Compression Therapy Market Trends

The Latin America market is growing in the compression therapy sector, driven by the rising incidence of Deep Vein Thrombosis (DVT) across the region. Increasing cases of DVT are largely associated with sedentary lifestyles, higher obesity rates, prolonged immobility, and a growing number of surgeries and hospital admissions, all of which elevate the risk of blood clot formation. In addition, long-distance travel and limited early-stage diagnosis in certain areas are contributing to the expanding patient pool. According to a 2025 study by the National Library of Medicine, a total of 700,315 admissions for venous thromboembolism were documented in the Brazilian public health system between 2008 and 2022, representing 3.02 admissions per 10,000 inhabitants per year. The Southeast region accounted for more than half (54.5%) of the hospitalizations.

As awareness of DVT and its complications improves, there is a greater emphasis on preventive care and post-treatment management, leading to higher adoption of compression therapy products such as stockings and bandages. Furthermore, the aging population in countries like Brazil and Argentina is accelerating demand, as elderly individuals are more vulnerable to venous disorders. The market is also supported by rising healthcare expenditure, improved healthcare infrastructure, and greater awareness among healthcare professionals and patients about effective treatment options.

Middle East and Africa Compression Therapy Market Trends

The compression therapy market in the Middle East and Africa is expected to register a significant CAGR during the forecast period, driven by increasing investments in healthcare infrastructure and the rising prevalence of chronic diseases. Advancements in the healthcare system are expected to boost the development of the medical device industry in this region. Growing health insurance penetration, increasing privatization, and rising regional disease burden are factors expected to drive regional market growth.

The Saudi Arabia compression therapy market is expected to grow at the fastest CAGR over the forecast period. In Saudi Arabia, the prevalence of CVI is significantly high, with 45.6% of the adult population affected, especially in the Western region. This high prevalence, higher than in Western countries, is linked to lifestyle factors and risk factors such as age, family history, prolonged standing occupation, and use of hormonal therapy. This scenario presents a competitive market for CVI treatment products and services, emphasizing the need for innovative solutions & targeted interventions to address the prevalent risk factors.

compression-therapy-market-advancements-compression-garments

Here are several key advancements in compression garments:

• Modern compression garments use breathable fabrics, moisture-wicking technology, and antimicrobial and hypoallergenic materials to improve comfort, reduce skin irritation, and prevent bacterial growth, while also reducing the risk of allergies and skin irritation
• Advanced knitting techniques enable varying compression levels within a garment, enhancing blood circulation by being strongest at the extremities and decreasing towards the core
• Advancements in body scanning and 3D printing technology enable personalized compression garments, providing optimal comfort and minimal waste, while 3D knitting technology enhances comfort and sustainability
• Modern compression garments use embedded sensors to monitor physiological parameters, enabling real-time performance optimization and health monitoring. Integration with mobile apps allows users to track progress, adjust training or treatment, and share information
• Compression garments offer fashionable options in various colors, patterns, and styles, and are designed for specific user groups like pregnant women, athletes, or patients recovering from specific surgeries
• Modern compression garments are enhanced by durable fabrics and easy care routines, making them resistant to wear and tear, deformation, and loss of compression

study-conducted-department-surgery

A patient-centric approach to compression therapy: the use and adoption of a novel mobile application to support the clinical selection of medical compression hosiery

Compression therapy is widely recognized as an effective treatment option for the management of lower limb conditions; however, clinicians do not always apply it appropriately. A lack of knowledge and clinical uncertainty, combined with an increased workload and less time with patients, might lead to inappropriate compression decisions.

A research article published in wound.uk in November 2023 studied the use of the Hosiery Hunter app (Medi UK) and its role in clinical decision-making. The Hosiery Hunter app is a new mobile app that simplifies the selection of medical compression hosiery for patients with lower-limb conditions. According to qualitative data from a user feedback survey, the Hosiery Hunter app made it easier to choose the most suitable compression therapy, saved time and delivered swift and timely access to codes for prescription.

Clinical Results and Studies

Tactile Medical has invested in several research studies that generate clinical and economic outcome data to support its product and demonstrate its effectiveness.To date, more than 25 studies on the safety and efficacy of the firm’s products have been completed, involving more than 2,100 subjects. A few of them studying the efficacy of Flexitouch System are listed below:

• Economic Impact of Tactile Medical’s Flexitouch System in Patients with Phlebolymphedema
• Impact on Clinical Outcomes and Healthcare Costs with Use of Flexitouch System
• Flexitouch System Impact on Limb Volume and Patient-Reported Outcome
• Comparison of Flexitouch System with Simple Pneumatic Compression Devices
• Study of Patient-Reported Satisfaction with Use of Flexitouch System
• Flexitouch System Impact on Patient-Reported Improved Quality-of-Life

Shifts Towards E-commerce

Digitalization transforms the way the company markets and sell products, solutions, and services, builds relationships with consumers, patients, and caregivers. Essity’s focus on digital channels reflects a broader industry trend of investing in e-commerce to cater to evolving consumer needs and behaviors.

Essity has expanded its distribution channels from offline to digital in recent years. Digital interactions with customers and consumers help understand their needs and improve communication and engagement. For instance, Medtronic has its Connect E-Store, an e-commerce platform designed to streamline order management for healthcare professionals and organizations. This platform enhances convenience by enabling easy access to essential medical products, simplifying procurement processes, and reducing ordering time through its user-friendly interface and advanced digital features. By improving accessibility and efficiency in purchasing medical supplies, such digital platforms support faster adoption of products like compression therapy devices, thereby contributing to the growth of the compression therapy market.

Key Compression Therapy Company Insights

Cardinal Health, Julius Zorn GmbH, Hartmann AG, Medi GmbH & Co., SIGVARIS, BSN Medical GmbH, ArjoHuntleigh, 3M Health Care, Spectrum Healthcare, Bio Compression Systems, Inc., and Stryker are some of the major players in the global market. The market has been witnessing notable trends that are impacting the activities of emerging players in the industry. These companies offer a wide range of compression garments, stockings, wraps, and devices for various medical conditions, including venous disorders, lymphedema, and wound healing. There is also a growing number of emerging players and startups entering the market, offering innovative solutions and disrupting traditional market dynamics. These companies often focus on niche segments or develop novel technologies to address unmet needs in wound care management and vascular health.

Moreover, advancements in compression therapy technologies have led to the development of innovative products and treatment modalities. Some notable advancements include; smart compression technology, 3D printing, gradient compression systems, cold compression therapy, hydrotherapy compression devices, etc. In addition, companies in the global market are focusing on developing patient-centric solutions that prioritize comfort, convenience, and usability.

Key Compression Therapy Companies:

The following key companies have been profiled for this study on the compression therapy market

• Essity Aktiebolag (publ).
• Cardinal Health
• Julius Zorn GmbH
• Hartmann AG
• Medi GmbH & Co.
• SIGVARIS
• ArjoHuntleigh
• 3M (Solventum)
• Spectrum Healthcare
• Bio Compression Systems, Inc.
• Stryker
• Gottfried Medical
• Tactile Medical

Competitive Benchmarking

Operating Strategies	Competitive Edge	Weaknesses
Mature Players: Essity Aktiebolag (publ)
Mature companies diversify and upgrade their product lines to meet a broader range of patient needs, such as introducing premium flat-knit custom garments, smart/connected hosiery, and advanced dynamic compression pumps. To grow beyond saturated home markets, mature firms pursue mergers, acquisitions, and partnerships to enter new regional markets or adjacent segments.	Extensive Product Portfolio: Offering a broad range of compression products: flat-knit, circular-knit, multi-layer bandages, hosiery, and dynamic compression devices. Covering all therapy classes (Class 1–4) and custom-made options to meet diverse patient needs. Strong Brand Recognition & Clinical Credibility: A well-established reputation fosters trust among healthcare providers, patients, and distributors. Clinical validation of products supports adoption and compliance.	Many mature players offer similar product features (e.g., compression levels, materials), making it challenging to differentiate purely on product attributes. Established supply chains and legacy manufacturing setups can result in higher fixed costs.
Emerging Players: AIROS Medical, Inc.
Focus on advanced materials (breathable fabrics, lightweight fibers, antimicrobial properties) to improve patient comfort and adherence. Focus on specialized compression hosiery for chronic conditions like lymphedema or venous insufficiency, where patient-specific customization is valued.	Innovation & Differentiation: Emerging players can quickly introduce advanced materials, smart compression devices, and patient-focused designs, offering solutions that combine medical efficacy with comfort and style. Targeting underserved segments like home healthcare, post-surgical recovery, or pediatric compression helps build strong brand loyalty and specialized market presence.	Emerging players often struggle with low brand awareness compared to established incumbents, making it harder to gain trust from patients and healthcare providers. Emerging players may face limitations in funding, R&D, and production capacity, restricting large-scale expansion and innovation.

Recent Developments

• In September 2025, AIROS Medical announced the expansion of its trunkal compression garment line to improve inclusivity for patients suffering from lymphedema. The newly introduced garments feature extended sizing options, enabling a broader range of patients with abdominal and pelvic swelling to access pneumatic compression therapy for effective edema and pain management.
• In October 2025, WRS Group announced that it had entered into a definitive agreement with Avanos Medical to acquire many assets and rights associated with the Game Ready orthopedic rental business in the U.S. The acquisition, effective from December 2025, strengthens WRS Group’s portfolio in orthopedic pain management and recovery solutions.
• In February 2025, Tactile Medical announced the expanded launch of its next-generation pneumatic compression platform, Nimbl™, to include patients with lower extremity lymphedema across the U.S. This expansion builds on the product’s initial introduction in October 2024, which was primarily focused on treating upper extremity lymphedema.
• In November 2024, Cardinal Health launched the Kendall SCD SmartFlow Compression System, an advanced medical device designed to enhance venous thromboembolism prevention in hospitalized patients. The system provides sequential compression therapy, which helps reduce the risk of deep vein thrombosis and pulmonary embolism.
• In November 2024, Scottish scientists from the University of Edinburgh developed a low-cost, flexible device to prevent blood clots. This represents a significant advancement in post-surgical care, particularly for patients at risk of developing conditions like Deep Vein Thrombosis (DVT). The device, a polymer-based sensor, fits under bandages and compression stockings and uses a handheld reader to measure whether the bandage is applying the correct pressure to the body.
• In October 2024, Tactile Medical launched the next-generation Nimbl Pneumatic Compression Platform, designed to enhance lymphedema management. This chronic condition results in swelling in the arms or legs due to a blockage in the lymphatic system. This innovative platform offers an advanced solution for patients suffering from lymphedema, providing an improved, more comfortable, and effective form of treatment.

Compression Therapy Market Report Scope

Report Attribute	Details
Market size value in 2026	USD 4.61 billion
Revenue forecast in 2033	USD 5.88 billion
Growth rate	CAGR of 3.54% from 2026 to 2033
Actual data	2021 – 2025
Forecast period	2026 – 2033
Quantitative units	Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, trends, and volume analysis
Segments covered	Technology, end use, distribution channel, and region
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope	U.S.; Canada; Mexico; UK; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil;  Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled	Essity Aktiebolag (publ); Cardinal Health; Julius Zorn GmbH; Hartmann AG; Medi GmbH & Co.; SIGVARIS; ArjoHuntleigh; 3M; Spectrum Healthcare; Bio Compression Systems, Inc.; Stryker; Gottfried Medical; Tactile Medical
Customization scope	Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to the country & segment scope.

Global Compression Therapy Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the compression therapy market report based on technology, end use, distribution channel, and region.

• Technology Outlook (Revenue, USD Million, 2021 – 2033)
  • Static Compression Therapy
    • Compression Bandages
    • Compression Stockings
    • Compression Tape
    • Others Compression Garments
  • Dynamic Compression Therapy
    • Compression Pumps
    • Compression Sleeves
• End Use Outlook (Revenue, USD Million, 2021 – 2033)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician’s Office
  • Nursing Homes
  • Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 – 2033)
  • Institutional Sales
  • Retail Sales
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

This report has been delivered with the following In-depth customizations

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Compression Therapy Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.1.2. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic vein disorders
3.2.1.2. Growing number of orthopedic procedures
3.2.1.3. Growing Incidence of obesity
3.2.1.4. Growing aging population
3.2.1.5. Rising awareness about non-invasive treatment options
3.2.2. Market Restraint Analysis
3.2.2.1. Alternative treatment method
3.2.2.2. Lack of awareness in rural and underdeveloped regions
3.2.3. Market Opportunities Analysis
3.2.3.1. Increasing adoption of home-based treatment solutions
3.2.3.2. Technological advancements
3.2.3.3. Growing demand in emerging markets
3.2.3.4. Expansion of e-commerce and retail distribution channels
3.2.3.5. Untapped rural healthcare markets
3.2.4. Market Challenge Analysis
3.2.4.1. Patient discomfort and compliance issues
3.2.4.2. Limited reimbursement policies in developing regions
3.3. Compression Therapy Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Compression Therapy Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Compression Therapy Market Movement Analysis
4.3. Global Compression Therapy Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. Static Compression Therapy
4.4.1. Static Compression Therapy Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.4.1.1. Compression Bandages
4.4.1.1.1. Compression Bandages Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.4.1.2. Compression Stockings
4.4.1.2.1. Compression Stockings Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.4.1.3. Compression Tape
4.4.1.3.1. Compression Tape Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.4.1.4. Other Compression Garments
4.4.1.4.1. Other Compression Garments Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.5. Dynamic Compression Therapy
4.5.1. Dynamic Compression Therapy Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.5.1.1. Compression Pumps
4.5.1.1.1. Compression Pumps Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.5.1.2. Compression Sleeves
4.5.1.2.1. Compression Sleeves Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 5. Compression Therapy Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Compression Therapy Market Movement Analysis
5.3. Global Compression Therapy Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.5. Specialty Clinics
5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.6. Home Healthcare
5.6.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.7. Physician’s Office
5.7.1. Physician’s Office Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.8. Nursing Homes
5.8.1. Nursing Homes Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 6. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Compression Therapy Market Movement Analysis
6.3. Global Compression Therapy Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.4. Institutional Sales
6.4.1. Institutional Sales Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
6.5. Retail Sales
6.5.1. Retail Sales Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 7. Compression Therapy Market: Regional Estimates & Trend Analysis By Technology, By End Use, By Distribution Channel
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Scenario
7.3.2.4. Reimbursement Scenario
7.3.2.5. U.S. Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Scenario
7.3.3.4. Reimbursement Scenario
7.3.3.5. Canada Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Scenario
7.3.4.4. Reimbursement Scenario
7.3.4.5. Mexico Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4. Europe
7.4.1. Europe Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Reimbursement Scenario
7.4.2.5. UK Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Reimbursement Scenario
7.4.3.5. Germany Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. Reimbursement Scenario
7.4.4.5. France Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. Reimbursement Scenario
7.4.5.5. Italy Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Reimbursement Scenario
7.4.6.5. Spain Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Reimbursement Scenario
7.4.7.5. Denmark Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Scenario
7.4.8.4. Reimbursement Scenario
7.4.8.5. Sweden Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Scenario
7.4.9.4. Reimbursement Scenario
7.4.9.5. Norway Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. Reimbursement Scenario
7.5.2.5. Japan Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Reimbursement Scenario
7.5.3.5. China Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. Reimbursement Scenario
7.5.4.5. India Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Scenario
7.5.5.4. Reimbursement Scenario
7.5.5.5. South Korea Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Scenario
7.5.6.4. Reimbursement Scenario
7.5.6.5. Australia Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Scenario
7.5.7.4. Reimbursement Scenario
7.5.7.5. Thailand Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. Reimbursement Scenario
7.6.2.5. Brazil Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. Reimbursement Scenario
7.6.3.5. Argentina Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.7. Middle East & Africa
7.7.1. Middle East & Africa Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Scenario
7.7.2.4. Reimbursement Scenario
7.7.2.5. South Africa Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Scenario
7.7.3.4. Reimbursement Scenario
7.7.3.5. Saudi Arabia Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Scenario
7.7.4.4. Reimbursement Scenario
7.7.4.5. UAE Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Scenario
7.7.5.4. Reimbursement Scenario
7.7.5.5. Kuwait Compression Therapy Market Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Essity Aktiebolag (publ).
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Cardinal Health
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Julius Zorn GmbH
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Hartmann AG
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Medi GmbH & Co.
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. SIGVARIS
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. ArjoHuntleigh
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. 3M
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Spectrum Healthcare
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Bio Compression Systems, Inc.
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Product Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. Stryker
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Product Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. Gottfried Medical
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Product Benchmarking
8.2.12.4. Strategic Initiatives
8.2.13. Tactile Medical
8.2.13.1. Company Overview
8.2.13.2. Financial Performance
8.2.13.3. Product Benchmarking
8.2.13.4. Strategic Initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Estimated Company Market Share Analysis, 2025
8.5. List of Other Key Market Players

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Compression Therapy Market, by Region, 2021 – 2033 (USD Million)
Table 4 Global Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 5 Global Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 6 Global Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 7 North America Compression Therapy Market, by Country, 2021 – 2033 (USD Million)
Table 8 North America Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 9 North America Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 10 North America Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 11 U.S. Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 12 U.S. Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 13 U.S. Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 14 Canada Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 15 Canada Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 16 Canada Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 17 Mexico Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 18 Mexico Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 19 Mexico Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 20 Europe Compression Therapy Market, by Country, 2021 – 2033 (USD Million)
Table 21 Europe Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 22 Europe Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 23 Europe Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 24 Germany Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 25 Germany Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 26 Germany Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 27 UK Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 28 UK Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 29 UK Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 30 France Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 31 France Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 32 France Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 33 Italy Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 34 Italy Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 35 Italy Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 36 Spain Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 37 Spain Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 38 Spain Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 39 Denmark Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 40 Denmark Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 41 Denmark Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 42 Sweden Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 43 Sweden Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 44 Sweden Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 45 Norway Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 46 Norway Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 47 Norway Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 48 Asia Pacific Compression Therapy Market, by Country, 2021 – 2033 (USD Million)
Table 49 Asia Pacific Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 50 Asia Pacific Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 51 Asia Pacific Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 52 China Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 53 China Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 54 China Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 55 Japan Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 56 Japan Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 57 Japan Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 58 India Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 59 India Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 60 India Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 61 South Korea Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 62 South Korea Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 63 South Korea Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 64 Australia Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 65 Australia Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 66 Australia Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 67 Thailand Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 68 Thailand Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 69 Thailand Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 70 Latin America Compression Therapy Market, by Country, 2021 – 2033 (USD Million)
Table 71 Latin America Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 72 Latin America Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 73 Latin America Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 74 Brazil Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 75 Brazil Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 76 Brazil Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 77 Argentina Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 78 Argentina Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 79 Argentina Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 80 Middle East & Africa Compression Therapy Market, by Country, 2021 – 2033 (USD Million)
Table 81 Middle East & Africa Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 82 Middle East & Africa Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 83 Middle East & Africa Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 84 South Africa Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 85 South Africa Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 86 South Africa Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 87 Saudi Arabia Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 88 Saudi Arabia Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 89 Saudi Arabia Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 90 UAE Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 91 UAE Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 92 UAE Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 93 Kuwait Compression Therapy Market, by Technology, 2021 – 2033 (USD Million)
Table 94 Kuwait Compression Therapy Market, by End Use, 2021 – 2033 (USD Million)
Table 95 Kuwait Compression Therapy Market, by Distribution Channel, 2021 – 2033 (USD Million)
Table 96 Participant’s Overview
Table 97 Financial Performance
Table 98 Product Benchmarking
Table 99 Strategic Initiatives

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Compression Therapy Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Compression Therapy Market, for Static Compression Therapy, 2021 – 2033 (USD Million)
Fig. 15 Global Compression Therapy Market, for Compression Bandages, 2021 – 2033 (USD Million)
Fig. 16 Global Compression Therapy Market, for Compression Stockings, 2021 – 2033 (USD Million)
Fig. 17 Global Compression Therapy Market, for Compression Tape, 2021 – 2033 (USD Million)
Fig. 18 Global Compression Therapy Market, for Other Compression Garments, 2021 – 2033 (USD Million)
Fig. 19 Global Compression Therapy Market, for Dynamic Compression Therapy, 2021 – 2033 (USD Million)
Fig. 20 Global Compression Therapy Market, for Compression Pumps, 2021 – 2033 (USD Million)
Fig. 21 Global Compression Therapy Market, for Compression Sleeves, 2021 – 2033 (USD Million)
Fig. 22 Global Compression Therapy Market, for Hospitals, 2021 – 2033 (USD Million)
Fig. 23 Global Compression Therapy Market, for Specialty Clinics, 2021 – 2033 (USD Million)
Fig. 24 Global Compression Therapy Market, for Home Healthcare, 2021 – 2033 (USD Million)
Fig. 25 Global Compression Therapy Market, for Physician’s Office, 2021 – 2033 (USD Million)
Fig. 26 Global Compression Therapy Market, for Nursing Homes, 2021 – 2033 (USD Million)
Fig. 27 Global Compression Therapy Market, for Others, 2021 – 2033 (USD Million)
Fig. 28 Global Compression Therapy Market, for Institutional Sales, 2021 – 2033 (USD Million)
Fig. 29 Global Compression Therapy Market, for Retail Sales, 2021 – 2033 (USD Million)
Fig. 30 Regional Outlook, 2025 & 2033
Fig. 31 North America Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 32 U.S. Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 33 Canada Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 34 Mexico Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 35 Europe Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 36 Germany Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 37 UK Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 38 France Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 39 Italy Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 40 Spain Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 41 Denmark Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 42 Sweden Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 43 Norway Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 44 Asia Pacific Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 45 Japan Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 46 China Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 47 India Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 48 Australia Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 49 South Korea Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 50 Thailand Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 51 Latin America Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 52 Brazil Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 53 Argentina Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 54 Middle East and Africa Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 55 South Africa Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 56 Saudi Arabia Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 57 UAE Compression Therapy Market, 2021 – 2033 (USD Million)
Fig. 58 Kuwait Compression Therapy Market, 2021 – 2033 (USD Million)